Login
$STLN
$6.59 +$0.30 (4.77%) Close

Company Executives

$STLN Management Team

Dr. Daniel Virnich

Chief Executive Officer

Director

Age 46
Compensation $1.118M USD
Sex Male

Mr. Brad Hively

Independent Vice Chairman of the Board

Age 46
Compensation $81.82K USD
Sex Male

Mr. Robert Carter

Chief Financial Officer

Principal Accounting Officer

Age 39
Compensation -
Sex Male

Dr. Yale Podnos

Chief Medical Officer

Age 54
Compensation $610.3K USD
Sex Male

Ms. Anne Mcgeorge

Independent Chairman of the Board

Age 64
Compensation $83.68K USD
Sex Female

Ms. Kristin England

Chief Administrative Officer

Age -
Compensation -
Sex Female

Mr. Nolan Mariano

Chief People Officer

Age -
Compensation -
Sex Male

Mr. Rakesh Panda

Chief Information Officer

Age -
Compensation -
Sex Male
Directors
8
serving now
Independent
6 of 6
stated in the proxy; 2 not stated
Average tenure
3.4 years
from year joined
CEO also chairs the board
No
Anne McGeorge
Director Age On board Independent Committees Other public boards 2025 pay Source
Brad Hively
47 2021
5 years
Not stated
Compliance Committee
None stated $315,000
Karen Johnson
65 2021
5 years
Independent
Nominating and Corporate Governance Committee · Chair Compliance Committee
None stated $350,001
Mohit Kaushal
47 2020
6 years
Independent
Compensation Committee · Chair
Emyria Pty Ltd. $369,999
Anne McGeorge
65 2021
5 years
Independent
Audit Committee Compensation Committee
Dianthus Therapeutics $424,998
Mark Pacala
70 2022
4 years
Independent
Audit Committee Compensation Committee
None stated $340,000
Mark Stolper
54 2026
0 years
Independent None stated None stated Not stated
Kimberly Tzoumakas
58 2026
0 years
Independent
Nominating and Corporate Governance Committee Compliance Committee
None stated Not stated
Daniel Virnich
47 2024
2 years
Not stated None stated None stated Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support